ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Search


Volume 4, Number 1, 2017
... housed in cages and used for treatment in groups of 13 animals. All the studies were approved by the Mechnikov Research Institute of Vaccines and Sera Committee on the Ethics of Animal Experiments and ...
Authors: Irina A. Leneva, Irina N. Falynskova, Nailya R. Makhmudova, Ekaterina A. Glubokova, Nadezhda P. Kartashova, Eugenia I. Leonova, Natalya A. Mikhailova, Irina V. Shestakova
Том 2, номер 1, 2015
... The system of genetic control of innate immune responses to influenza infection and gene function allows for the development of systemic treatment of influenza with a focus on the phenotype ...
Authors: О.И. Киселев, А.Б. Комиссаров, О.С. Коншина, М.Н. Дмитриева, Э.Г. Деева, Т.В. Сологуб, В.И. Покровский
Volume 2, Number 1, 2015
... The system of genetic control of innate immune responses to influenza infection and gene function allows for the development of systemic treatment of influenza with a focus on the phenotype of ...
Authors: O. I. Kiselev, A. B. Komissarov, O.S.Konshina, M.N.Dmitrieva, E.G.Deyeva, T.V.Sologub, V.I.Pokrovskiy
Том 4, номер 1, 2017
... . The antiviral drug triazavirine is licensed in Russia for the treatment and prophylaxis of acute respiratory infections, including influenza A and B viruses. In the present study, we investigated the ...
Authors: И. А. Ленева, И. Н. Фалинскова, Н. Р. Махмудова, Е. А. Глубокова, Н. П. Карташова, Е. И. Леонова, Н. А. Михайлова, И. В. Шестакова
Volume 2, Number 1, 2015
... diagnostic becomes especially important. The early identification of the influenza infection makes it possible to prescribe the corresponding treatment to the patient at the very beginning of the illness in ...
Authors: Vera Krivitskaya, Evgeniy Sorokin, Tatyana Tsareva, Ekaterina Petrova, Nadezhda Konovalova, Maria Pisareva, Zhanna Buzitskaya, Tatyana Smirnova, Anna Sominina
Volume 1, number 1, 2014
... , Germany), and incubated overnight with 1% BSA (Sigma-Aldrich, Austria) in PBS. After that, the cells were stained with mouse anti-influenza virus A NP antibodies (Millipore, USA) followed by treatment ...
Authors: Mariia Sergeeva, Artem Krokhin, Mikhail Matrosovich, Tatyana Matrosovich, Markus Wolschek, Oleg Kiselev, Julia Romanova
Volume 5, Number 1, 2018
... are no vaccines and effective antiviral drugs for the prevention and treatment of pneumoviruses as well as for the most respiratory viruses of non-influenza etiology. Table 1 ...
Authors: Andrej Egorov
Volume 3, Number 1, 2016
... respiratory viral infections account for approx. 77% of the total damage from all infectious diseases. Significant losses are related both to the direct costs of patients’ treatment and ...
Authors: Andrej Y. Egorov
Volume 4, Number 1, 2017
... these drugs was discovered quite recently.
Bacterial resistance to this class of antibiotics emerged as a result of their widespread use for the treatment of ...
Authors: Alexander Zhivich